New study reveals Ozempic doesn’t work in the way we originally thought

Ozempic could not work the identical manner as scientists all the time believed

The burden-loss injection, which grew to become all the fad with A-list celebrities, is now thought to have an effect on person’s metabolism, not simply their urge for food.

The drug semaglutide, offered beneath the model names Wegovy and Ozempic, had been recognized to advertise emotions of fullness within the individuals who take them by interacting with fullness hormones and slowing down digestion so the abdomen stays bodily fuller for longer.

“It all the time appeared oversimplistic to me that these new remedies had been simply making individuals eat much less,” stated analysis lead Professor Donal O’Shea in an announcement. “So, this research is an thrilling step ahead in our understanding of how these new medicines for weight problems work.”

“The findings additionally present science to assist the truth that the therapy of weight problems shouldn’t be merely to eat much less and transfer extra—that’s the prevention piece. The therapy is extra advanced than that.”

The research noticed 30 individuals with obstructive sleep apnea and weight problems taking glucagon-like peptide 1 analogs drop some pounds and improve their metabolism and other people with a sluggish metabolism in the beginning of the research appeared to expertise probably the most advantages.

It got here as Tory management contender Robert Jenrick admitted he beforehand used the Ozempic weight-loss jab however “didn’t significantly take pleasure in it”.

The previous immigration minister confirmed he took the treatment for round six weeks final autumn to shed some kilos.

Mr Jenrick was addressing rumours about his sudden weight reduction over the previous yr after he reappeared in Westminster with a noticeably slimmer determine since leaving authorities.